Viewing Study NCT06725758


Ignite Creation Date: 2025-12-25 @ 12:22 AM
Ignite Modification Date: 2026-03-27 @ 12:58 AM
Study NCT ID: NCT06725758
Status: RECRUITING
Last Update Posted: 2024-12-10
First Post: 2024-11-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Two-part, First-in-Human Study on ODM-212 in Subjects with Selected Advanced Solid Tumours
Sponsor: Orion Corporation, Orion Pharma
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module